Metabolic studies of formestane in horses.

The research article is about the metabolic studies of formestane, a steroidal aromatase inhibitor, in horses. The researchers aim to identify the metabolite with the longest detection time that could be used to control formestane abuse in horse racing.

Objectives and Background of the Research

• The main aim of this research is to understand the metabolic pathway of formestane in horses. The researchers want to identify the metabolite with the longest detection time that could serve as an indicator of formestane use.
• Formestane is a steroidal aromatase inhibitor that is known to be abused in human sports. It was detected in a horse urine sample in 2011, marking the first reported case of formestane use in a racehorse. While the metabolism of formestane in humans has been previously studied, little is known about its metabolic fate in horses.
• This research was instigated by the need to control formestane abuse in horses, as it can distort fair competition and potentially harm the animal’s health.

Methods of the Research

• Metabolic studies of formestane were performed in both in vitro and in vivo settings.
• In vitro studies were conducted using homogenized horse liver, and seven in vitro metabolites were identified.
• The in vivo studies involved two thoroughbred geldings who were each administered with 800 mg of formestane. Urine samples were collected post-administration and analyzed for the presence of the parent drug and its metabolites.

Findings of the Research

• The research observed that the metabolite 4-hydroxytestosterone (M1), found in the glucuronide-conjugated fraction, was the ideal candidate for monitoring formestane administration due to its longevity. M1 could be detected up to 34 hours post-administration.
• Additionally, the parent drug formestane could also be detected in blood samples up to 34 hours after administration.

Implication of the Research

• The findings from this study will assist in controlling formestane abuse in horse racing. By monitoring for 4-hydroxytestosterone (M1) in urine samples of racehorses, authorities can effectively detect formestane use and ensure fair competition and animal safety.